These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7886179)

  • 1. Are schizophrenic symptoms different in patients with higher education?
    Cernovsky ZZ; Landmark J; Helmes E
    Psychol Rep; 1994 Dec; 75(3 Pt 2):1552-4. PubMed ID: 7886179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender, premorbid characteristics and negative symptoms in schizophrenia.
    Fennig S; Putnam K; Bromet EJ; Galambos N
    Acta Psychiatr Scand; 1995 Sep; 92(3):173-7. PubMed ID: 7484193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale.
    van Mastrigt S; Addington J
    J Psychiatry Neurosci; 2002 Mar; 27(2):92-101. PubMed ID: 11944510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicidal behavior in schizophrenia: a test of the demoralization hypothesis.
    Restifo K; Harkavy-Friedman JM; Shrout PE
    J Nerv Ment Dis; 2009 Mar; 197(3):147-53. PubMed ID: 19282679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of hysterical symptoms in schizophrenic patients.
    Cernovsky ZZ; Landmark J
    Psychol Rep; 1994 Aug; 75(1 Pt 1):251-5. PubMed ID: 7984733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [French translation of the Chapman Social and Physical Anhedonia Questionnaire: validation of the French translation in controls and schizophrenic patients].
    Assouly-Besse F; Dollfus S; Petit M
    Encephale; 1995; 21(4):273-84. PubMed ID: 7588166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
    Kelly DL; Feldman S; Boggs DL; Gale E; Conley RR
    Compr Psychiatry; 2010; 51(3):298-302. PubMed ID: 20399340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition.
    Penadés R; Gastó C; Boget T; Catalán R; Salamero M
    Compr Psychiatry; 2001; 42(1):64-9. PubMed ID: 11154718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nosologic specificity of psychopathologic findings in schizophrenic and depressed patients].
    Schneider F; Böser H; Heimann H; Fus I; Friedrich J
    Wien Klin Wochenschr; 1992; 104(3):51-5. PubMed ID: 1570706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homogeneity and heterogeneity in schizophrenia.
    Herron WG; Diamond E
    Percept Mot Skills; 1991 Apr; 72(2):561-2. PubMed ID: 1852564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of 16 systems to diagnose schizophrenia.
    Herron WG; Schultz CL; Welt AG
    J Clin Psychol; 1992 Nov; 48(6):711-21. PubMed ID: 1452759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in schizophrenia: rehospitalization and community survival.
    Angermeyer MC; Goldstein JM; Kuehn L
    Psychol Med; 1989 May; 19(2):365-82. PubMed ID: 2762441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the reliability of reported premorbid adjustment in schizophrenic patients.
    Small NE; Mohs RC; Halperin R; Rosen WG; Masterson C; Kendler KS; Horvath TB; Davis KL
    Biol Psychiatry; 1984 Feb; 19(2):203-11. PubMed ID: 6713037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1993 Jan; 18(1):18-23. PubMed ID: 8461276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predicting the job performance of schizophrenic patients].
    Richter A; Blaha L; Gross W; Schreiber W
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S35-7. PubMed ID: 15570495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [InSka (Intentionality Scale)--a new psychopathometric instrument for the detection of schizophrenic residual symptoms].
    Mundt C; Fiedler P; Pracht B; Rettig R
    Nervenarzt; 1985 Mar; 56(3):146-9. PubMed ID: 3990882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.